GlassScriptPhysician profile
Steven A Curley
NPI 1942309075
$162,171.07
in general payments reported to CMS, 2019-2025
17 companies · $50K in 2025
The $50K reported for 2025 was more than what 99% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,206 · 2020: $4,171 · 2021: $6,234 · 2022: $2,495 · 2023: $560 · 2024: $97K · 2025: $50K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $126K · Travel and Lodging: $22K · Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $125,505.00 |
| Travel and Lodging | $22,316.29 |
| Food and Beverage | $243.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $147,810.70 | 2021-2025 | |
| Abbvie INC. | $9,098.50 | 2019-2023 | Linzess |
| Ethicon Endo-Surgery INC. | $2,020.00 | 2022-2023 | Neuflex |
| Stryker Corporation | $1,129.11 | 2019-2021 | |
| Medical Device Business Services, INC. | $883.46 | 2021-2022 | |
| Ethicon US, LLC | $365.16 | 2019-2022 | |
| Avanos Medical | $332.64 | 2019-2024 | On-Q* Pump and Accessories |
| Ipsen Biopharmaceuticals, INC | $160.42 | 2019 | |
| Medtronic, INC. | $92.20 | 2022 | |
| Angiodynamics, INC. | $84.30 | 2019 | |
| Davol INC. | $51.06 | 2021-2023 | Phasix Mesh |
| Smith+Nephew, INC. | $32.49 | 2020 | |
| Stemline Therapeutics INC. | $29.41 | 2025 | Orserdu |
| Astrazeneca Pharmaceuticals LP | $23.81 | 2025 | |
| Nestle Healthcare Nutrition INC. | $22.37 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kite Pharma, INC. | $19.34 | 2022 | |
| Misonix INC | $16.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Curley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.